Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Nanotechnology for Delivery of Gemcitabine to Treat Pancreatic Cancer Publisher Pubmed



Birhanu G1, 2 ; Javar HA3 ; Seyedjafari E4 ; Zandikarimi A4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, International Campus (TUMS-IC), Tehran, Iran
  2. 2. School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
  3. 3. Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Biotechnology, College of Science, University of Tehran, Tehran, Iran

Source: Biomedicine and Pharmacotherapy Published:2017


Abstract

Pancreatic cancer (PC) is one of the most deadly and quickly fatal human cancers with a 5-year mortality rate close to 100%. Its prognosis is very poor, mainly because of its hostile biological behavior and late onset of symptoms for clinical diagnosis; these bring limitations on therapeutic interventions. Factors contributing for the difficulties in treating PC include: high rate of drug resistance, fast metastasis to different organs, poor prognosis and relapse of the tumor after therapy. After being approved by US FDA 1997, Gemcitabine (Gem) is the first line and the gold standard drug for all stages of advanced PC till now. However, its efficacy is unsatisfactory, mainly due to; its chemical instability and poor cellular uptake, resulting in an extremely short half-life and low bioavailability. To solve this drawbacks and increase the therapeutic outcome important progress has been achieved in the field of nanotechnology and offers a promising and effective alternative. This review mainly focus on the most commonly investigated nanoparticle (NP) delivery systems of Gem for PC treatment and the latest progresses achieved. Novel nanocarriers with better tumor targeting efficiencies and maximum treatment outcome to treat this deadly due are given much attention. © 2017 Elsevier Masson SAS
Other Related Docs
10. Smart Internal Stimulus-Responsive Nanocarriers for Drug and Gene Delivery, Smart internal stimulus-responsive nanocarriers for drug and gene delivery (2015)
15. Toxicology of Nanobiomaterials, Stem Cell Nanoengineering (2015)
17. Ph-Sensitive Stimulus-Responsive Nanocarriers for Targeted Delivery of Therapeutic Agents, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (2016)
23. Novel Drug Delivery Strategies for Improving Econazole Antifungal Action, International Journal of Pharmaceutics (2015)
29. Bioavailability, Biodistribution, and Toxicity of Fluorescent Metal Nanoclusters, Luminescent Metal Nanoclusters: Synthesis# Characterization# and Applications (2022)
32. Electrospun-Based Systems in Cancer Therapy, Electrospun Materials for Tissue Engineering and Biomedical Applications: Research# Design and Commercialization (2017)
36. An Update on Nanoparticle-Based Contrast Agents in Medical Imaging, Artificial Cells# Nanomedicine and Biotechnology (2018)
37. Toxicity Concerns of Nanocarriers, Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and Genes (2017)
38. Cancer Genetics at a Glance: The Comprehensive Insights, Cancer Genetics and Psychotherapy (2017)
40. Silk Fibroin Nanoparticle As a Novel Drug Delivery System, Journal of Controlled Release (2015)
43. Recent Advances on the Application of Nanobiomimetic Structures As Drug Delivery Systems, Journal of Drug Delivery Science and Technology (2024)